Botulinum Toxin A to Treat Arm Tremor

Completed · Phase 2 · Has a placebo group

Conditions studied: Essential Tremor of the Upper Limbs

In brief

The objective of this study is to assess the efficacy and safety of a single, kinematic-analysis-based intramuscular injection of NT 201, compared with placebo, in moderate to marked essential tremor of the upper limb.

Key facts

Study ID

NCT02207946

Run by

Merz Pharmaceuticals GmbH

People needed

30

Starts

2014-12-05

Expected to finish

2016-09-26

Last updated by the study team

2021-02-18

Who can join

Age: 18 and older. Sex: any. Healthy volunteers: not accepted.

Where it is running

• Merz Investigational Site #0010191 — New York, New York, United States
• Merz Investigational Site #0010317 — Winnipeg, Manitoba, Canada
• Merz Investigational Site #0010089 — Halifax, Nova Scotia, Canada
• Merz Investigational Site #0010078 — Toronto, Ontario, Canada
• Merz Investigational Site #0010305/1 — Toronto, Ontario, Canada
• Merz Investigational Site #0010305/2 — Toronto, Ontario, Canada

Full record on ClinicalTrials.gov

Trial information comes from ClinicalTrials.gov and is refreshed daily. TrialsForMe does not provide medical care and does not run the studies it lists.